| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Epstein-Barr virus susceptible immature T-cell line, WILL4, established from a patient with T-lymphoblastic lymphoma bearing CD21 and a clonal EBV genome
|
Hosoi, Hiroki
|
|
2017
|
55 |
C |
p. 1-5
5 p.
|
artikel
|
| 2 |
Anti-cancer effect of clofazimine as a single agent and in combination with cisplatin on U266 multiple myeloma cell line
|
Durusu, İpek Z.
|
|
2017
|
55 |
C |
p. 33-40
8 p.
|
artikel
|
| 3 |
Characterization of treatment and outcomes in a population-based cohort of patients with chronic lymphocytic leukemia referred for cytogenetic testing in British Columbia, Canada
|
Huang, Steven J.
|
|
2017
|
55 |
C |
p. 79-90
12 p.
|
artikel
|
| 4 |
Clinical significance of isolated del(7p) in myeloid neoplasms
|
Gur, Hatice Deniz
|
|
2017
|
55 |
C |
p. 18-22
5 p.
|
artikel
|
| 5 |
Combination of cytogenetic classification and MRD status correlates with outcome of autologous versus allogeneic stem cell transplantation in adults with primary acute myeloid leukemia in first remission
|
Yao, Jianfeng
|
|
2017
|
55 |
C |
p. 97-104
8 p.
|
artikel
|
| 6 |
Comment on “KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study”
|
Hughes, Amy
|
|
2017
|
55 |
C |
p. 55-57
3 p.
|
artikel
|
| 7 |
Current approach to the treatment of chronic myeloid leukaemia
|
Pasic, Ivan
|
|
2017
|
55 |
C |
p. 65-78
14 p.
|
artikel
|
| 8 |
Editorial board and publication information
|
|
|
2017
|
55 |
C |
p. IFC-
1 p.
|
artikel
|
| 9 |
Increase of IRF-1 gene expression and impairment of T regulatory cells suppression activity on patients with myelodysplastic syndrome: A longitudinal one-year study
|
Perazzio, Aline S.B.
|
|
2017
|
55 |
C |
p. 6-17
12 p.
|
artikel
|
| 10 |
Simvastatin ameliorates graft-vs-host disease by regulating angiopoietin-1 and angiopoietin-2 in a murine model
|
Zheng, Peng
|
|
2017
|
55 |
C |
p. 49-54
6 p.
|
artikel
|
| 11 |
The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma
|
Burwick, Nicholas
|
|
2017
|
55 |
C |
p. 23-32
10 p.
|
artikel
|
| 12 |
The epigenetically-regulated miR-34a targeting c-SRC suppresses RAF/MEK/ERK signaling pathway in K-562 cells
|
Yang, Yang
|
|
2017
|
55 |
C |
p. 91-96
6 p.
|
artikel
|
| 13 |
Unexpected cross-reactivity of anti-cathepsin B antibodies leads to uncertainties regarding the mechanism of action of anti-CD20 monoclonal antibody GA101
|
Chien, Wei Wen
|
|
2017
|
55 |
C |
p. 41-48
8 p.
|
artikel
|
| 14 |
Use of 5-azacitidine for therapy-related myeloid neoplasms in patients with concomitant active neoplastic disease
|
Annereau, M.
|
|
2017
|
55 |
C |
p. 58-64
7 p.
|
artikel
|
Tijdschrift beschrijving